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Abstract
Background: Insufficient iodine intake in pregnancy is associated with many adverse pregnancy outcomes. About
90% of African countries are at risk of iodine deficiency due to poor soils and dietary goitrogens. Pregnancy
predisposes to insufficient iodine nutrition secondary to increased physiological demand and increased renal loss.
Iodine deficiency is re-emerging in countries thought to be replete with pregnant women being the most affected.
This review seeks to identify the degree of iodine nutrition in pregnancy on the entire African continent before and
after the implementation of national iodization programmes.
Methods: A systematic search of published literature will be conducted for observational studies that directly
determined the prevalence of insufficient iodine intake among pregnant women in Africa. Electronic databases and
grey literature will be searched for baseline data before the implementation of population-based iodine supplementation
and for follow-up data up to December 2018. Screening of identified articles and data extraction will be conducted
independently by two investigators. Risk of bias and methodological quality of the included studies will be assessed using
a risk of bias tool. Appropriate meta-analytic techniques will be used to pool prevalence estimates from studies with
similar features, overall and by major characteristics including the region of the study, time period (before and after
implementation of iodization programmes), sample size and age. Heterogeneity of the estimates across studies will be
quantified and publication bias investigated. This protocol is reported according to Preferred Reporting Items for
Systematic reviews and Meta-Analysis protocols (PRISMA-P) 2015 guidelines.
Discussion: This review will help ascertain the impact of national iodization programmes on the iodine nutrition status in
pregnancy in Africa and advise policy on the necessity for monitoring and mitigating iodine deficiency in pregnancy in
Africa. This review is part of a thesis that will be submitted to the Faculty of Health Sciences, University of Cape Town, for
the award of a PhD in Medicine whose protocol has been granted ethics approval (UCT HREC 135/2018). In addition, the
results will be published in a peer-reviewed journal.
Systematic review registration: PROSPERO CRD42018099434
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Strengths and limitations of this study
 This will be the first systematic review and meta-
analysis aiming to estimate the level of iodine
deficiency among pregnant women in Africa.
 Methodological and statistical procedures that will
be used to derive accurate estimates are robust and
reliable.
 This review may be limited by the degree of
accuracy of the various methods used to measure
urine iodine concentration.
 Since urine iodine concentration varies according to
the time day when the sample was collected, this
may introduce some degree of heterogeneity
 Further heterogeneity may be introduced by studies
with small sample sizes.
Background
Although iodine deficiency affects over 2 billion people
worldwide and is re-emerging in formerly iodine-replete
industrialised countries, pregnant women, lactating mothers
and their offspring are more susceptible to the adverse
effects of iodine deficiency [1]. These include stillbirths, mis-
carriages, intrauterine growth restriction, postpartum thy-
roiditis, subclinical and overt hypothyroidism, dyslipidemia,
neuro-cognitive and psychomotor deficits [2–4].
In endemic areas, chronic iodine deficiency among
women in reproductive age will be exacerbated by the in-
creased renal clearance and loss in urine which will pre-
dispose the foetus to defective neuronal migration,
myelination and glial differentiation which are key features
of brain central nervous system development [4, 5]. This
is the underlying cause of cretinism in severe cases and
neurocognitive and psychomotor deficits. Hence, whole
generations will be at risk of chronic thyroid, metabolic
and mental diseases, leading to low socio-economic prod-
uctivity in areas without sustained adequate nutrition [2].
There is a trend towards the re-emergence of iodine
deficiency in iodine-replete countries such as the USA,
the UK, New Zealand and Australia [6–9]. This has par-
tially been attributed to inadequate use of iodized salt
and voluntary instead of universal iodisation of salt used
in commercial and household food production. As a re-
sult, the median urine iodine concentration (UIC) in the
USA declined from 320 μg/l to 144 μg/l between 1971
and 2010 while pregnancy median UIC fell from 153 μg/
l between 2001 and 2006 to insufficient levels <150 μg/l
between 2007 and 2010 [6–8]. Data from a survey of 21
European countries in 2014 revealed that despite the
iodine status of some countries being adequate across all
age groups, 13/21 countries had inadequate iodine in-
take during pregnancy due to poor access to iodized
foodstuffs and inadequate of monitoring of iodine nutri-
tion status [9].
Iodine deficiency is widespread in Africa such that
without iodine supplementation, almost 90% of the
population will be at risk of iodine deficiency [10–12].
This is mainly due to iodine-deficient soils and goitro-
gens of which the most significant being poorly detoxi-
fied cassava which is rich in thiocyanate [13].
By early 1996, iodine deficiency disorder control pro-
grammes using iodised salt as the long-term strategy
had been initiated in almost all of the 50 countries in Af-
rica where WHO estimated that iodine deficiency dis-
order was of public health significance. As a result, more
than 50% of the salt consumed in Africa was iodised
[14]. Although universal iodisation of salt is the main
source of dietary iodine in most African countries, other
major sources of dietary iodine in some African coun-
tries include groundwater in Somalia and Djibouti and
bouillon cubes and canned and processed foods such as
in Senegal and Ghana [1, 15–18].
By 2017, 85% of the African countries had achieved
sufficient iodine nutrition in the general population [19].
However, only four of the eleven African countries that
had median pregnancy UIC survey data (South Africa,
Tanzania, Sierra Leone and Ghana) had adequate iodine
intake during pregnancy; five (Burkina Faso, Egypt,
Niger, Morocco, and Senegal) had insufficient intake
during pregnancy, while Djibouti and Liberia had more
than enough iodine intake during pregnancy.
Since about 90% of dietary iodine intake is excreted in
the urine, the World Health Organization (WHO) rec-
ommended that urinary iodine concentration (UIC) is a
good marker of recent iodine intake. Hence, median
UIC has been used to map out populations at increased
risk of thyroid disorders due to iodine deficiency [20].
The median school-age children (SAC) UIC is com-
monly used to estimate the iodine nutrition status of the
most population, but this may underestimate the degree
of iodine deficiency in pregnancy due to differing dietary
habits of SAC and pregnant women, in addition to spe-
cific physiological changes of pregnancy [9, 21, 22].
During pregnancy, the urinary iodine excretion in-
creases by about 30–50% secondary to the increased
blood volume, hyperdynamic state and the increased
renal blood flow and glomerular filtration [23, 24]. Fur-
thermore, serum iodide concentration is progressively
reduced in the second and third trimesters by increased
trans-placental transfer to the growing foetus which be-
gins production of thyroid hormones from about 20
weeks’ gestation [25]. In addition, there is extra iodine
demand due to the physiological increase in maternal
thyroid hormone output. This is as a result of the
oestrogen mediated increase in thyroid-binding globulin
that progressively decreases the free T4 in the serum,
transfer of iodine to the foetus and increased renal iod-
ine clearance [26]. Therefore, women with mild-to-
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moderate iodine deficiency may develop severe iodine
deficiency in pregnancy with resultant subclinical
hypothyroidism (SCH), overt hypothyroidism (OH) or
isolated T4 deficiency with resultant maternal and off-
spring short term and long-term complications [25–27].
Hence, the WHO recommends that the average iodine
intake to maintain normal thyroid clearance and cater
for renal losses in pregnancy should be at least 200 μg
daily for pregnant women compared to 100–150 μg per
day for non-pregnant women [1]. Among pregnant
women, a median UIC < 150, 150–249, 250–499 and >
500 μg is considered an estimate of, respectively, insuffi-
cient, adequate, more than adequate and excessive iod-
ine nutritional status [28].
However, there is a paucity of data on the magnitude
of iodine deficiency among pregnant women on the con-
tinent of Africa [29] and around the globe [19]. We in-
tend to conduct a systematic review and meta-analysis
of observational studies carried out to establish the trend
in the state of iodine nutrition among pregnant women
in Africa following the implementation of national
iodization programmes.
Rationale
Although much gain in access to iodised salt has been
achieved in most African countries since the early 1990s,
of recent, the implementation of universal salt
iodization, the major method of iodine supplementation,
seems to be slowing down [7]. Due to challenges with
monitoring [30], it is not clear if iodine deficiency may
be re-emerging in African countries as in industrialised
nations. Like elsewhere around the globe, women in re-
productive age, pregnant women and their children will
be the most affected, yet the degree of iodine deficiency
in pregnancy in Africa is not well documented.
Although the most recent Iodine Global Network (IGN)
data suggests that 85% of the African countries have suffi-
cient iodine nutrition in the general population [19],
further evaluation of these statistics using the method de-
scribed by De Benoist et al [30] reveals that 30% of these
countries have more than > 50% of the general population
with a median UIC < 100 μg/L. This implies a high risk of
insufficient iodine intake at the inception of pregnancy
among women in reproductive age given that adequate
iodine nutrition status in pregnancy is defined by median
UIC of 150–249 μg/L [1]. It is recommended that preg-
nant and lactating women, who make up the most vulner-
able portion of the general population, should be
considered for supplementation with iodine until the
population-based iodization programme is scaled up. Not
only is it necessary to achieve sufficient iodine nutrition
status, but it is also equally important to sustain adequate
iodine nutrition status of the entire population especially
the most vulnerable portions. Hence, the impact of
iodization should be monitored at a regional or national
level at least every 5 years.
Objectives
The aim of this systematic review and meta-analysis is
to ascertain the trend in the prevalence of insufficient
iodine nutrition status (median UIC < 150 μg/L) among
pregnant women in Africa following the implementation
of national iodization programmes and to establish if
this has had a sustainable positive impact on the iodine
nutrition status of pregnant women in Africa.
Review questions
The purpose of this review is to address the following
questions:
1. What was the prevalence of insufficient iodine
intake (UIC < 150 μg/L) among pregnant women on
the various African countries before the
implementation of national iodine deficiency
disorder control programmes?
2. How has the iodine nutrition status during
pregnancy changed in the various African countries
following the implementation of national iodine
deficiency disorder control programmes between
1994 and 31 December 2018?
3. What was the iodine nutrition status of pregnant
women in various African countries between 2005
(the year designated by the WHO for the
elimination of iodine deficiency through national




The selection of studies for inclusion in the review will
be guided by the Population, Intervention/exposure,
Comparison and Outcome protocol as stipulated below.
The population comprises of pregnant women on the
African continent, the exposure is the period during the
implementation of iodine deficiency disorder control pro-
grammes from 1994 to 2018, and the comparison is the
period before the implementation of iodine deficiency dis-
order control programmes in 1994. The outcome is the
iodine nutrition status during pregnancy in Africa.
Cross-sectional, case-control and cohort studies con-
ducted on iodine deficiency among pregnant women in
Africa with data available on mean or median urine iod-
ine concentration will be included in this systematic re-
view. The iodine nutrition status will be defined
according to the WHO/ICCIDD classification of iodine
intake of populations using median urinary iodine con-
centration [1]. All studies reported in the English,
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French or Portuguese languages and conducted on hu-
man subjects will be considered.
Exclusion criteria
Studies with the following characteristics will be ex-
cluded: studies conducted among populations of African
origin but residing outside Africa, studies lacking preva-
lence rates and with the absence of data to compute
them, case series with small sample sizes (sample less
than 30 participants), and studies not performed in hu-
man participants or published in languages other than
English, French and Portuguese.
Source of information
The methods of this systematic review are reported in
accordance with the Preferred Reporting Items for Sys-
tematic reviews and Meta-Analysis protocols (PRISMA-
P) 2015 Guidelines [31] (Additional file 1: Table S1).
Search strategy for study identification
Electronic searches
We will search PubMed-MEDLINE, Google Scholar,
SCOPUS, ISI Web of Science (Science Citation Index),
Africa Wide Information, African Index Medicus (AIM)
and AFROLIB databases for published studies on iodine
deficiency in pregnancy in Africa up to 31 December
2018. This search shall be conducted using a predefined
comprehensive and sensitive search strategy combining
relevant terms with names of countries in Africa, to
obtain the maximum possible number of studies. This
search will be guided by the African search filter, which
has been reported to have good sensitivity (and im-
proved precision) of 74% (1.3–9.4%) and 73% (5–28%)
for MEDLINE and EMBASE, respectively [32]. This
search filter includes names of each African country and
shortened terms to capture studies from regions. Coun-
tries with official names in a language other than English
will also be entered in the official form, and for countries
that have changed names over time, both names shall be
included in the search. Table 1 depicts the main search
strategy to be employed. We will search reference lists of
relevant citations for articles of interest.
Grey literature
We will search for national ministries of health, inter-
national organisations such as the WHO, UNICEF,
ICCIDD and IGN, other non-government organisations’
reports, conference and workshop proceedings using
Google Scholar search engine and major relevant web-
sites such as WHO African Index Medicus and African
Journals Online (AJOL). Key experts in the field will be
contacted for any unpublished study.
Study records
Data management
All identified entries will be entered into endnote soft-
ware for de-duplication of records. Prior to the screening
of studies, investigators shall create standardised ques-
tions according to the inclusion criteria which will then
be pre-tested on a sample of eligible studies.
Screening
Two investigators will independently select studies that
meet inclusion criteria. Citations and abstracts will be
screened for possible inclusion, and duplicate citations
will be excluded. Titles and abstracts will then be
screened following inclusion criteria described above,
Table 1 Search strategy for MEDLINE and adaptability to
regional databases
Search Search items Hits
1 iodine deficiency [tw] OR iodine insufficiency [tw] OR
insufficient iodine intake [tw] OR insufficiency iodine
nutrition [tw] OR iodine
2 urine iodine excretion [tw] OR urine iodine concentration
[tw] OR urinary iodine excretion [tw] OR urinary iodine
concentration [tw] OR urine iodine
3 Pregnancy [tw] OR Pregnant women [tw] OR expectant
mothers [tw] first trimester [tw] [tw] OR second trimester
[tw] third trimester [tw]
4 #1 AND #3
5 #2 AND #3
6 African filter((((Angola[tw] OR Benin[tw] OR Botswana[tw]
OR “Burkina Faso”[tw] OR Burundi[tw] OR
Cameroon[tw] OR “Cape Verde”[tw] OR “Central African
Republic”[tw] OR Chad[tw] OR Comoros[tw] OR
Congo[tw] OR “Democratic Republic of Congo”[tw] OR
Djibouti[tw] OR “Equatorial Guinea”[tw] OR Eritrea[tw]
OR Ethiopia[tw] OR Gabon[tw] OR Gambia[tw] OR
Ghana[tw] OR Guinea[tw] OR “Guinea Bissau”[tw] OR
“Ivory Coast”[tw] OR “Cote d’Ivoire”[tw] OR Kenya[tw]
OR Lesotho[tw] OR Liberia[tw] OR Madagascar[tw] OR
Malawi[tw] OR Mali[tw] OR Mauritania[tw] OR Mauritius[tw]
OR Mozambique[tw] OR Namibia[tw] OR Niger
[tw] OR Nigeria[tw] OR Principe[tw] OR Reunion[tw] OR
Rwanda[tw] OR “Sao Tome”[tw] OR Senegal[tw] OR
Seychelles[tw] OR “Sierra Leone”[tw] OR Somalia[tw]
OR “South Africa”[tw] OR Sudan[tw] OR Swaziland[tw]
OR Tanzania[tw] OR Togo[tw] OR Uganda[tw] OR
“Western Sahara”[tw] OR Zambia[tw] OR Zimbabwe[tw]
OR “Central Africa”[tw] OR “Central African”[tw] OR “West
Africa”[tw] OR “West African”[tw] OR “Western
Africa”[tw] OR “Western African”[tw] OR “East Africa”[tw]
OR “East African”[tw] OR “Eastern Africa”[tw] OR
“Eastern African”[tw] OR “South African”[tw] OR “Southern
Africa”[tw] OR “Southern African”[tw] OR “sub
Saharan Africa”[tw] OR “sub Saharan African”[tw] OR
“subSaharan Africa”[tw] OR “subSaharan African”[tw]
NOT “guinea pig” [tw] NOT “guinea pigs” [tw] NOT
“aspergillus niger” [tw]))))
7 # 4 AND # 6 Limits: 01/01/1990 to 31/12/2018 in English,
French, and Portuguese on humans
8 # 5 AND # 6 Limits: 0109/1990 to 31/12/2018 in English,
French, and Portuguese on humans
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following which the full texts of potentially eligible arti-
cles will be obtained. These full texts will be screened
using a standardised and pre-tested form to include eli-
gible studies. Disagreements will be resolved by consen-
sus or consultation of a third author. Corresponding
authors of potentially eligible studies that did not report
data that are relevant to our study analysis will be con-
tacted. Reasons for exclusion of non-eligible studies will
be documented. The whole selection process will be
summarised in a flow chart.
Data extraction
Two investigators will independently extract data from
included studies, using a standardised and pre-tested data
extraction form. Any inconsistencies or disagreement shall
be resolved by consensus or consultation with the third
investigator.
Data items
Data will include the geographic region and country
where study was conducted, the year study was carried
out and year of publication, the language of publication,
demographic characteristics of participants (such as mean
age), study design, setting (rural or urban, health-facility
or community-based), sample size, and the criteria used
for determination of the iodine intake. The median (25th–
75th percentiles) and or mean (standard deviation) UIC
will be recorded.
Assessment of methodological quality and risk of bias
Two reviewers will independently score the quality of in-
cluded studies. The STROBE checklist [33] will be used
to evaluate reporting methodology in each paper while
risk of bias in individual studies will be assessed using
the risk of bias tool for prevalence studies [34] (Table 2)
and the Cochrane guidelines available in Review Man-
ager V.5.3 (http://tech.cochrane.org/revman).
Discrepancies will be resolved by consensus or by
consulting the third investigator. Inter-rater agreement on
screening, data abstraction and methodological quality will
be assessed using Cohen’s κ coefficient [35]. We intend to
present the risk of bias and quality scores in a table.
Data synthesis, analysis and assessment of heterogeneity
Prevalence data will be summarised by country and
country-specific geographic regions where applicable
(Table 3). For studies with sufficient data, meta-analysis
using random effects models will be conducted overall,
that is, across all possible eligible studies. In addition, we
will conduct subgroup analysis according to major
study-level characteristics such as by country, regions
within Africa (as defined by the United Nations); the
time period of data collection: before 2005 and after
2005 (the target year for elimination of iodine deficiency
through national iodization programmes); the period de-
fined as before and after the implementation of national
iodization programmes; and the sample size (below vs.
at or above median sample size across included studies)
and by age group (below vs. at or above median mean
age across included studies). Other criteria for subgroup
analyses will include urinary iodine assessment methods
and study design. Data will be presented as forest plots
showing estimates of mean UIC in pregnancy. For data
unsuitable for meta-analysis, we will provide a narrative
description of major study characteristics and trends
over time.
Study-specific estimates will be pooled after stabilising
the variance of individual studies with the use of
Freeman-Tukey double arc-sine transformation [36].
This transformation will help reduce the effect of
extremely high or extremely low prevalence rates on the
pooled estimate. Heterogeneity will be evaluated by the
Cochrane’s Q statistic and I2. I2 values of 25%, 50% and
75% will respectively be deemed to represent low,
medium and high heterogeneity, respectively. Funnel
plots together with the Egger test of bias will be used to
investigate the publication bias [37].
Table 2 Risk of bias assessment tool
Risk of bias item Yes = 1
No = 0
External validity
1 Was the study target population a close
representation of the national population
in relation to relevant variables?
2 Was the sampling frame a true or close
representation of the target population?
3 Was some form of random selection used
to select the sample, OR, was a census
undertaken?
4 Was the likelihood of non-participation
bias minimal?
Internal validity
5 Were data collected directly from the
participants (as opposed to medical
records)?
6 Were acceptable case definitions of
iodine deficiency in pregnancy used?
7 Were reliable and accepted diagnostic
methods for iodine intake utilised?
8 Was the same mode of data collection
used for all participants?
9 Were the numerator(s) and denominator(s)
for the calculation of the iodine intake
appropriate?
Summary of the
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Sensitivity analysis
Subgroup analysis using the variables mentioned above
and further analysis according to the quality of the stud-
ies will be carried out in order to identify possible
sources of the heterogeneity. If subgroup differences are
identified, they will be described, and the data will be
interpreted in light of these differences.
The Duval and Tweedie trim-and-fill will be used to
adjust estimates for the effects of potential publication
bias. Data analyses will use the ‘meta’ package of the
statistical software R (version 3.3.3 [2017-03-06], The R
Foundation for statistical computing, Vienna, Austria),
and the ‘meta’ package.
Reporting of this review
The proposed systematic review will be reported follow-
ing the PRISMA guidelines [38]. We intend to publish a
PRISMA checklist alongside the final report.
Potential amendments
We do not intend to make any amendments to the
protocol, to avoid the possibility of outcome reporting
bias. However, any amendments that do prove necessary
will be documented and reflected online on the PROS-
PERO website where the protocol has been registered
[PROSPERO CRD42018099434].
Discussion
The degree of iodine nutrition during pregnancy all over
the African continent following the implementation of
USI and other methods of iodization is not known with
certainty. It is not certain whether the trend towards the
re-emergence of iodine deficiency among pregnant
women in several developed countries around the world
is also affecting pregnant women in Africa. A high
prevalence of iodine deficiency among pregnant women
in Africa would imply an enormous but probably unrec-
ognised predisposition to iodine deficiency disorders af-
fecting not only pregnant women but also lactating
mothers and their offspring. The association of iodine
deficiency in pregnancy with various adverse pregnancy
outcomes and chronic neurocognitive, psychomotor thy-
roid and cardiovascular diseases among mothers and
their offspring requires concerted attention. This review
seeks to address the knowledge gap on the magnitude of
insufficient iodine intake among pregnant women on the
African continent. The data will help shed light on the
magnitude of iodine deficiency in pregnancy in Africa
which can help inform policy makers on the degree and
desirable methods for intervention and the appropriate
frequency of monitoring of iodine nutrition status in
pregnancy.
Possible limitations of this study would include a pre-
dominance of poor quality studies and significant het-
erogeneity of studies precluding further analysis.
Additional file
Additional file 1: Table S1. PRISMA-P 2015 checklist. (DOCX 30 kb)
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